Latest KFF Health News Stories
Nuevas drogas contra el cáncer, ¿ayudan a vivir más?
Empujados por defensores de pacientes que quieren acceso temprano a los medicamentos, la FDA ha aprobado una ráfaga de drogas oncológicas en los últimos años, Pero pocas de estas drogas han permitido a pacientes con una esperanza de vida limitada, vivir por años.
Pharmacies Thrive Selling Opioids For Depressed Small Town Pain
Prescription pain pills are strong sellers in this southeastern Kentucky region that’s long struggled with high rates of joblessness and poor health.
Drugmaker Kaleo Raises Price Of Lifesaving Drug By Thousands
Kaiser Health News reporter Shefali Luthra discusses the controversy surrounding Kaleo, a company that makes a life-saving auto-injector for opioid drug overdoses on Weekend Edition.
Luke Whitbeck’s life was saved by a rare disease drug, but it costs $300,000 a year.
Women Fear Drug They Used To Halt Puberty Led To Health Problems
Despite questions about Lupron’s lasting side effects and minimal study into its safety, the FDA sped approval of the drug to market. Years later, some young women are still living with the consequences.
Por qué es tan difícil hallar una cura para el Alzheimer
A pesar de una tasa de fracaso de 99%, científicos que investigan el Alzheimer están avanzando con cientos de experimentos -y un gran impulso en dinero federal- para tratar de revertir una enfermedad mortal que los ha desconcertado por décadas.
Trying To Solve The Alzheimer’s Puzzle
Alzheimer’s researchers hold onto hope after another promising trial ends in disappointment.
Drug Prices, Opioids, And Obamacare: A Conversation With Assemblyman Jim Wood
Wood, who chairs the Assembly Health Committee, lays out his priorities for 2017.
Getting Patients Hooked On An Opioid Overdose Antidote, Then Raising The Price
The device, known as Evzio, administers just enough naloxone to stabilize someone who has overdosed on drugs. But its manufacturer, Kaleo, may be positioning itself to find profits in a dire health care crisis.
KHN Video: Orphan Drugs Creating Gold Rush For Pharmaceutical Firms
The designation, which is made by the Food and Drug Administration, allows drugmakers to claim seven years of market exclusivity.
Sky-High Prices For Orphan Drugs Slam American Families And Insurers
Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
Una investigación de Kaiser Health News analiza las acciones de compañias farmacéuticas para manipular los precios de medicamentos huérfanos, utilizados para tratar enfermedades raras.
Drugmakers Manipulate Orphan Drug Rules To Create Prized Monopolies
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed multiple times, an investigation shows.
Follow the twists and turns of the orphan drug industry over the past three decades.
Interactive: How Orphan Drugs Win The ‘Monopoly’ Game
Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.
Video: Former U.S. Rep. Henry Waxman Shares Deep Concerns About Orphan Drugs
The former Congressman championed the Orphan Drug Act decades ago but now he fears it’s being manipulated to make money.
Video Highlights: Obama’s Farewell: I’ll Support ‘Demonstrably Better’ ACA Replacement
President Barack Obama recounted his health care accomplishments in his farewell address to the nation Tuesday night.
A Peer Recovery Coach Walks The Frontlines Of The Opioid Epidemic
Charlie Oen was addicted to heroin as a teenager. At 25, he’s now clean and a peer counselor in Lima, Ohio, where he tries to help people who started using drugs before he was born.
Millones de personas buscan medicamentos más baratos fuera de EE.UU.
Por los altos precios de los medicamentos, millones de personas, en general respetuosas de la ley, han reaccionado cometiendo un acto ilegal: comprándolos fuera de los Estados Unidos.
Medicare Pays For A Kidney Transplant, But Not The Drugs To Keep It Viable
The federal government pays for kidney transplants. But the program only pays for essential anti-rejection drugs for three years. Many people can’t afford them and can end up losing the kidney.
